News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shin Nippon Biomedical Laboratories And Tranzyme Pharma To Co-Develop New Animal Model Using Primates



10/19/2005 5:10:58 PM

Shin Nippon Biomedical Laboratories (SNBL) has announced that it has agreed with Tranzyme Pharma of North Carolina to collaborate in developing new animal models. Under this alliance, Tranzyme Pharma will provide SNBL with its proprietary genetic technologies like "TexT," and SNBL will apply the technologies to cells and tissues of experimental primates. The joint efforts will help further develop new drugs and medical technologies.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES